← FDA Drug Approvals (Drugs@FDA)
FEBUXOSTAT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BEIJING SL PHARMA CO LTD · Approved 2018-12-31
Drug application
- FDA Application #
ANDA211339- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FEBUXOSTAT
- Generic name
- Febuxostat
- Active ingredients
- FEBUXOSTAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- BEIJING SL PHARMA CO LTD
- First approval
- 2018-12-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown